You are here: Products\Immunoassays\Resistin Mouse ELISA:

Resistin Mouse ELISA

Other names: RSTN, FIZZ3, ADSF, Adipose Tissue-Specific Secretory Factor
Cat. No.: RD293016100R Regulatory status: RUO
Size: 96 wells (1 kit) |
Files: Datasheet PDF (RUO) MSDS (RUO)
Legend: new product new product
discount discount
temporarily out of stock temporarily out of stock
book in advance order in advance

Research topic

Animal studies, Energy metabolism and body weight regulation

Features

  • The total assay time is less than four hours.
  • Quality control is mouse serum based.
  • Components of the kit are ready-to-use (with the exception of Dilution Buffer and

Wash Solution).

Storage/Shipping

Store the kit at 2–8°C. Under these conditions, the kit is stable until the expiration date (see label on the box).

Summary

Resistin, a product of the RSTN gene, is a peptide hormone belonging to the class of cysteine-rich secreted proteins which is termed the RELM family, and is also described as ADSF (Adipose Tissue-Specific Secretory Factor) and FIZZ3 (Found in Inflammatory Zone). Human resistin contains 108 amino acids as a prepeptide, and its hydrofobic signal peptide is cleaved before its secretion. Resistin circulates in human blood as a dimeric protein consisting of two 92 amino acid polypeptides, which are disulfide-linked via Cys26. Resistin may be an important link between obesity and insulin resistance. Mouse resistin, specifically produced and secreted by adipocyte, acts on skeletal muscle myocytes, hepatocytes and adipocytes themselves so that it reduces their sensitivity to insulin. Steppan et al. have suggested that resistin suppresses the ability of insulin to stimulace glucose uptake. They have also suggested that resistin is present at elevated levels in blood of obese mice, and is down regulated by fasting and antidiabetic drugs. Way et al., on the other hand, have found that resistin expression is severly suppressed in obesity and is stimulated by several antidiabetic drugs. Other studies have shown that mouse resistin increases during the differentiation of adipocytes, but it also seems to inhibit adipogenesis. In contrast, the human adipogenic differentiation is likely to be associated with a down regulation of resistin gene expression. Recent studies have shown that human resistin is expressed also in macrophages and may be a novel link between inflammation and insulin resistance.

Assay format

Sandwich ELISA, Biotin-labelled antibody

Sample requirements

1 µl/well

Applications

Cell culture medium, Plasma-Citrate, Plasma-EDTA, Serum

Calibration Curve

Limit of detection

Analytical Limit of Detection is calculated from the real Resistin values in wells and is 5pg/ml

Limit of quantification

Assay Sensitivity takes the dilution of samples into consideration and is calculated according to the formula: Assay Sensitivity = Analytical Limit of Detection x sample dilution = 5pg/ml x 100 = 0.5ng/ml

Intra-assay (Within-Run, n=8)

CV = 4.6 %

Inter-assay (Run-to-Run, n=8)

CV = 5.5 %

Spiking Recovery

100 %

Dilution Linearity

103 %

Cross-Reactivity

Mouse, Human, Hamster, Rat

References to this product

  • Haluzik MM, Lacinova Z, Dolinkova M, Haluzikova D, Housa D, Horinek A, Vernerova Z, Kumstyrova T, Haluzik M . Improvement of insulin sensitivity after peroxisome proliferator-activated receptor-alpha agonist treatment is accompanied by paradoxical increase of circulating resistin levels. Endocrinology . Sep;147(9):4517-24 (2006)
  • Kurlawalla-Martinez Cm Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H . Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol . Mar;25(6):2498-510 (2005)
  • Burnett MS, Lee CW, Kinnaird TD, Stabile E, Durrani S, Dullum MK, Devaney JM, Fishman C, Stamou S, Canos D, Zbinden S, Clavijo LC, Jang GJ, Andrews JA, Zhu J, Epstein SE . The potential role of resistin in atherogenesis. Atherosclerosis . Oct;182(2):241-8 (2005)

References to summary

  • Steppan C.M., Lazar M.A.: The current biology of resistin. Journal of Internal Medicine. 255, 439–447, (2004).
  • Maebuchi M, Machidori M, Urade R, Ogawa T, Moriyama T: Low resistin levels in adipose tissues and serum high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Archiv Biochem Biophys. 416, 164–170, (2003)
  • Steppan C.M., Lazar M.A.: Resistin and obesity-associated insulin resistance. TRENDS in Endocrinology and Metabolism. 13 (1), 18–23, (2002)
  • Pravenec M, Kazdová L, Landa V, Zídek V, Mlejnek P, Jansa P, Wang J, Qi N, Kurtz TW: Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem. 278, 45209–45215, (2001)
  • Banerjee R.R., Lazar M.A.: Dimerization of resistin and resistin–like moleules is determined by a single cystein. The Journal of Biological Chemistry. 276, 25970–25973, (2001)
  • Kim KH. et al.: A Cysteine-rich Adipose Tissue-specific Secretory Factors Inhibits Adipocte Differentiation. The Journal of Biological Chemistry. 276 (14), 11252–11256, (2001)
  • Steppan C.M. et al.: The Hormone Links Obesity to Diabetes. Nature. 409, 307–312, (2001)
  • Way J.M. et al.: Adipose Tissue Resistin Expression Is Severly Suppressed in Obesity and Stimulated by Peroxisome Proliferator-activated Receptor g Agonists. The Journal of Biological Chemistry. 276 (28), 25651–25653, (2001)
  • Hartman H.B., Lazar M.A. at al.: Mechanisms Regulating Adipocyte Expression of Resistin. The Journal of Biological Chemistry. 277 (22), 19754–19761, (2002)
  • Fasshauer M. at al.: Tumor Necrosis Factor a Is a Negative Regulator of Resistin Gene Expression and Secretion in 3T3-L1 Adipocytes. Biochemical and Biophysical Research Communications. 208, 1027–1031, (2001)
  • Steppan C.M. at al.: A Family of Tissue-specific Resistin-like Molecules. Proc. Natl. Acad. Sci. USA. 98 (2), 502–506, (2001)
  • Juan CC. at al.: Suppressed Gene Expression of Adipocyte Resistin in an Insulin-resistant Rat Model Probably by Elevated Free Fatty Acids. Biochemical and Biophysical Research Communications. 289, 1328–1333, (2001)


Shopping cart

Your cart is empty.